GPP
OLMA icon

Great Point Partners’s Olema Pharmaceuticals OLMA Stock Holding History

Great Point Partners’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,000,000
Closed -$11.9M – 29
2024
Q3 		$11.9M Buy
1,000,000
+203,120
+25% +$2.6M 3.51% 13
2024
Q2 		$8.62M Buy
+796,880
New +$8.64M 1.65% 23
2021
Q4 		– Sell
-329,086
Closed -$9.07M – 44
2021
Q3 		$9.07M Hold
329,086
– – 2.11% 20
2021
Q2 		$9.21M Buy
+329,086
New +$9.36M 1.93% 24

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Great Point Partners's OLMA Position: Q4 2024 in Review

Great Point Partners sold out of Olema Pharmaceuticals (OLMA) in Q4 2024, closing a stake of 1,000,000 shares — an estimated $11.9M sold.

Great Point Partners first reported a position in OLMA in Q2 2021 and held it in 4 quarters. The position peaked at $11.9M in Q3 2024. 156 funds tracked by Wall St. Rank hold OLMA as of Q4 2024.

  • Great Point Partners reported no remaining Olema Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Great Point Partners sold 1,000,000 Olema Pharmaceuticals shares in Q4 2024, an estimated $11.9M.
  • Great Point Partners first reported a position in Olema Pharmaceuticals in Q2 2021 and held it in 4 quarters.
  • Great Point Partners's Olema Pharmaceuticals position peaked at $11.9M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2024.

Based on Great Point Partners's 13F filing for Q4 2024, filed 14 Feb 2025.